Valuation Inter Pharma

Stocks

End-of-day quote Thailand S.E. 28/08/2026			5-day change	1st Jan Change
5.050 ^THB	0.00%		-0.98%	+9.78%

08-14	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	2,699	5,811	5,513	3,353	1,949	2,785
Change	-	115.34%	-5.13%	-39.19%	-41.86%	42.86%
Enterprise Value (EV) ¹	2,666	5,993	5,275	3,339	2,158	2,904
Change	-	124.78%	-11.98%	-36.69%	-35.37%	34.56%
P/E	50.2x	54.2x	40.6x	66x	52.3x	22.8x
PBR	5.73x	7.63x	2.86x	1.75x	1.01x	1.35x
PEG	-	0.6x	33.47x	-1.1x	-2x	0x
Capitalization / Revenue	6.04x	6.31x	3.59x	1.86x	1.02x	1.26x
EV / Revenue	5.97x	6.51x	3.44x	1.86x	1.13x	1.31x
EV / EBITDA	32.4x	35x	25.3x	19.9x	15.6x	10.7x
EV / EBIT	34x	41.1x	30.7x	30.5x	28.6x	15.1x
EV / FCF	112x	-18.9x	134x	-63.8x	-22.3x	31.7x
FCF Yield	0.89%	-5.3%	0.75%	-1.57%	-4.48%	3.16%
Dividend per Share ²	0.0103	-	0.1108	0.0214	-	0.073
Rate of return	0.18%	-	1.22%	0.39%	-	1.59%
EPS ²	0.1147	0.2214	0.2241	0.0839	0.0616	0.2022
Distribution rate	8.98%	-	49.4%	25.5%	-	36.1%
Net sales ¹	446.9	921	1,534	1,799	1,912	2,214
EBITDA ¹	82.3	171.4	208.7	167.7	138.3	272.5
EBIT ¹	78.5	145.8	171.7	109.4	75.53	192
Net income ¹	53.78	105.2	119.2	50.79	37.28	122.4
Net Debt ¹	-32.53	181.5	-238.3	-13.3	208.9	119.3
Reference price ²	5.758	12.000	9.108	5.538	3.220	4.600
Nbr of stocks (in thousands)	468,650	484,267	605,346	605,346	605,344	605,344
Announcement Date	25/02/21	25/02/22	28/02/23	01/03/24	25/02/25	02/03/26

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INTER PHARMA	-	-	-	-	92.42M
ELI LILLY AND COMPANY	33.44x	12.14x	24.6x	0.59%	1,047B
JOHNSON & JOHNSON	29.82x	-	-	2%	646B
ABBVIE INC.	32.61x	7.57x	15.74x	2.68%	451B
ROCHE HOLDING AG	19.99x	4.75x	11.76x	2.79%	355B
NOVARTIS AG	21.76x	5.62x	13.93x	2.85%	291B
ASTRAZENECA PLC	20.88x	4.29x	12.24x	2.06%	252B
AMGEN INC.	27.35x	7.07x	12.56x	2.33%	234B
NOVO NORDISK A/S	13.25x	4.77x	9.95x	3.83%	203B
GILEAD SCIENCES, INC.	-44.51x	6.43x	25.11x	2.26%	181B
Average	17.17x	6.58x	15.74x	2.38%	365.94B
Weighted average by Cap.	24.24x	8.07x	17.81x	1.97%